Hemolytic anemias, including sickle cell disease, thalassemia, and their variants SSDI Claims in Kentucky

Medical criteria

SSA Blue Book listing

7.05 Hemolytic anemias, including sickle cell disease, thalassemia, and their variants

Listing criteria (20 CFR Appendix 1, Part A)

(see 7.00C), with: A. Documented painful (vaso-occlusive) crises requiring parenteral (intravenous or intramuscular) narcotic medication, occurring at least six times within a 12-month period with at least 30 days between crises. OR B. Complications of hemolytic anemia requiring at least three hospitalizations within a 12-month period and occurring at least 30 days apart. Each hospitalization must last at least 48 hours, which can include hours in a hospital emergency department or comprehensive sickle cell disease center immediately before the hospitalization (see 7.00C2). OR C. Hemoglobin measurements of 7.0 grams per deciliter (g/dL) or less, occurring at least three times within a 12-month period with at least 30 days between measurements. OR D. Beta thalassemia major requiring life-long RBC transfusions at least once every 6 weeks to maintain life (see 7.00C4).

Body system category

7.00 Hematological Disorders

Common denial reason

Hemolytic anemia claims are commonly denied when hemoglobin levels, transfusion history, or vaso-occlusive crises do not meet listing frequency or severity.